Innovator IBD Breakout Opportunities ETF (BOUT) Price, Holdings, & News

ETF Overview

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.

Key Stats

• Today's Range: $39.24 to $39.57
• 50-Day Range: $38.61 to $41.38
• 52-Week Range: $32.53 to $42.41
• Volume: 1,009 shs
• Average Volume: 2,997 shs
• Market Capitalization: $15.70 million
• Assets Under Management: $14.32 million
• Dividend Yield: 1.02%
• Net Expense Ratio: 0.85%
• Aggregate Rating: Moderate Buy

BOUT ETF - Frequently Asked Questions

How have BOUT shares performed this year?

Innovator IBD Breakout Opportunities ETF's stock was trading at $39.07 at the start of the year. Since then, BOUT shares have increased by 0.5% and is now trading at $39.26.
View the best growth stocks for 2025 here.

Who are Innovator IBD Breakout Opportunities ETF's major shareholders?

Top institutional investors of Innovator IBD Breakout Opportunities ETF include Citadel Advisors LLC (8.99%) and Murphy & Mullick Capital Management Corp (0.16%).

How do I buy shares of Innovator IBD Breakout Opportunities ETF?

Shares of BOUT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Innovator IBD Breakout Opportunities ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Innovator IBD Breakout Opportunities ETF investors own include NVIDIA (NVDA), ARK Innovation ETF (ARKK), CRISPR Therapeutics (CRSP), Carvana (CVNA), Fastly (FSLY), Luckin Coffee (LKNCY) and Cloudflare (NET).

Fund Details

• Issuer: Innovator Capital Management
• Fund Name: Innovator IBD Breakout Opportunities ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NYSEARCA
• Current Symbol: NYSEARCA:BOUT
• Inception Date: 9/13/2018
• Fund Manager: Dustin Lewellyn, Ernesto Tong, Anand Desai
• Web: N/A
• Phone: N/A

Fund Focus

• Asset Class: Equity
• Benchmark: IBD Breakout Stocks Index
• Category: Broad Equity
• Focus: Strategy
• Development Level: Developed Markets
• Region: North America
• Number of Holdings: 76

Fund Statistics

• Assets Under Management: $14.32 million
• Average Daily Volume: $2,716.00
• Discount/Premium: -0.10%

Administrator, Advisor and Custodian

• Administrator: U.S. Bancorp Fund Services, LLC
• Advisor: Innovator Capital Management, LLC
• Custodian: U.S. Bank, N.A.
• Distributor: Foreside Fund Services, LLC
• Transfer Agent: U.S. Bank, N.A.
• Trustee: N/A
• Lead Market Maker: Virtu Financial

Options

• Optionable: N/A
• Short Interest: 100 shs

Miscellaneous

• Outstanding Shares: 400,000
• Beta: 1.03
• Creation Unit: 50,000
• Creation Fee: $250.00